BPC
CARM

Banque Pictet & Cie’s Carisma Therapeutics CARM Stock Holding History

Banque Pictet & Cie’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-569
Closed -$127K – 481
2014
Q3 		$127K Sell
569
-17
-3% -$4.04K ﹤0.01% 447
2014
Q2 		$154K Buy
+586
New +$145K ﹤0.01% 440

Other funds holding CARM

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Banque Pictet & Cie's CARM Position: Q4 2014 in Review

Banque Pictet & Cie sold out of Carisma Therapeutics (CARM) in Q4 2014, closing a stake of 569 shares — an estimated $127K sold.

Banque Pictet & Cie first reported a position in CARM in Q2 2014 and held it in 2 quarters. The position peaked at $154K in Q2 2014. 41 funds tracked by Wall St. Rank hold CARM as of Q4 2014.

  • Banque Pictet & Cie reported no remaining Carisma Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 569 Carisma Therapeutics shares in Q4 2014, an estimated $127K.
  • Banque Pictet & Cie first reported a position in Carisma Therapeutics in Q2 2014 and held it in 2 quarters.
  • Banque Pictet & Cie's Carisma Therapeutics position peaked at $154K in Q2 2014.
  • 41 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2014.

Based on Banque Pictet & Cie's 13F filing for Q4 2014, filed 12 Feb 2015.